Avidity Biosciences, Inc.RNA

Market cap

$9.2B

P/E ratio

	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	321	320	340	185	220
Marketable securities	-	-	270	410	1,282
Prepaid and other assets	-	-	12	16	41
Total current assets	332	411	623	611	1,542
Property and equipment, net	1	5	6	8	13
Restricted cash	0	0	0	0	3
Right-of-use assets	-	11	9	8	6
Other assets	1	1	1	0	1
Total assets	334	428	639	629	1,564
Accounts payable and accrued liabilities	8	14	33	34	70
Accrued compensation	3	9	11	14	4
Lease liabilities, current portion	-	2	3	4	4
Deferred revenue, current portion	4	5	5	28	21
Total current liabilities	15	30	52	81	98
Operating Lease, Liability, Noncurrent	1	10	8	6	3
Deferred revenue, net of current portion	12	7	1	41	38
Total liabilities	28	46	61	128	139
Commitments and Contingencies	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	0	0
Additional paid-in capital	-	-	-	1,071	2,315
Accumulated other comprehensive income	-0	-0	-3	0	3
Accumulated deficit	-67	-184	-358	-571	-893
Total stockholders’ equity	306	381	578	501	1,425
Total liabilities and stockholders’ equity	334	428	639	629	1,564